HealthRX.com · Printable medication review sheet
Care-transition supplement card: NMN or NR after 65
A one-page handoff for every move between primary care, specialists, hospital and rehabilitation: the exact product, why you take it, the outcome you are tracking, and what each team decided. Keep it with the bottle and give a copy to your caregiver.
The product, exactly as labelled
Copy these from the bottle, not from memory, and keep the packaging so the formulation stays identifiable.
Brand and product name
Named ingredient and amount per capsule or scoopNMN, NR, or a blend
Other ingredientsniacin, pterostilbene, botanical extracts
Amount you actually take each day
Start date, and every dose change with its date
Why you take it
The outcome you agreed to track
Outcomewalking distance, rising from a chair, fatigue, glucose readings
Where it stood before you started, with the date
Date to judge whether it is helping
Handoff log
Fill in a line at every admission, discharge, rehabilitation start, new specialist or major medicine change.
| Date | Care setting (clinic, hospital, rehab) | Who reviewed it | Continue, hold or stop | Reason given |
|---|---|---|---|---|
New symptoms since starting
| Date | Symptom (nausea, diarrhea, rash, sleep change, bruising) | Product and amount that day | Told whom |
|---|---|---|---|
What the trials behind this page found
- In a 24-week placebo-controlled study of 14 older men with diabetes and impaired physical performance (average age 81.1), NMN 250 mg a day was safe but did not improve grip strength or walking speed.[1]
- NMN 1,250 mg a day for 24 weeks in adults aged 65 or older did not improve auditory function or physical performance.[2]
- The NR plus pterostilbene trial in adults aged 60 to 80 compared two doses of the combination with placebo, taken at breakfast for 8 weeks; it had no NR-alone group.[3]
- Tell your providers about every supplement as far ahead of an operation as possible.[4]
- If side effects start, stop the supplement and contact your health care provider.[4]
Questions for each care team
- Should I continue, hold or stop this product while I am in your care, and when do we revisit it?
- Does anything in the formula, such as niacin, pterostilbene or a botanical, matter for my current medicines or recent test results?
- After this hospital stay or medicine change, which supplements should I restart, and in what order?
- Who keeps the updated list, and can my caregiver have a copy?
- If the outcome I am tracking has not changed by the review date, should I stop rather than take more?
Sources for the facts on this sheet
- Akasaka H, Nakagami H, Sugimoto K, et al. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study. Geriatr Gerontol Int 2023. PMID 36443648. https://pubmed.ncbi.nlm.nih.gov/36443648/
- npj Aging, Nature Portfolio. Sustained NAD⁺ augmentation by high-dose nicotinamide mononucleotide supplementation in older adults: a 24-week randomized, double-blind, placebo-controlled trial. Accessed 2026-10-18. https://www.nature.com/articles/s41514-026-00482-7
- Dellinger RW, Santos SR, Morris M, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD(+) levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis 2017. PMID 29184669. https://pubmed.ncbi.nlm.nih.gov/29184669/
- National Center for Complementary and Integrative Health (NIH). Using Dietary Supplements Wisely. Accessed 2026-10-18. https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.